Fertility and Autoimmune Disease

Handbook of Systemic Autoimmune Diseases

Volumn 4, Issue , 2005, Pages 29-42

  Gurtcheff, Shawn ^a   Hatasaka, Harry ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649641307     PISSN: 15715078     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1571-5078(05)04004-3     Document Type: Review

References (111)

1. McCarthy M. The gender gap in autoimmune disease. Lancet 356 9235 (2000) 1088
2. Mosher W.D., and Pratt W.F. Fecundity and infertility in the United States: incidence and trends. Fertil. Steril. 56 2 (1991) 192-193
3. Abma J.C., et al. Fertility, family planning, and women's health: new data from the 1995 National Survey of Family Growth. Vital. Health Stat. 23 19 (1997) 1-114
4. Isaksson R., and Tiitinen A. Present concept of unexplained infertility. Gynecol. Endocrinol. 18 5 (2004) 278-290
5. Martin J.A., et al. Births: final data for 2000. Natl. Vital. Stat. Rep. 50 5 (2002) 1-101
6. Martin J.A., et al. Births: final data for 2002. Natl. Vital. Stat. Rep. 52 10 (2003) 1-113
7. Tietze C. Reproductive span and rate of reproduction among Hutterite women. Fertil. Steril. 8 1 (1957) 89-97
8. Alamanos Y., et al. Epidemiology of systemic lupus erythematosus in northwest Greece 1982-2001. J. Rheumatol. 30 4 (2003) 731-735
9. Lind P., et al. Epidemiology of thyroid diseases in iodine sufficiency. Thyroid 8 12 (1998) 1179-1183
10. Meirow D., Laufer N., and Schenker J.G. Ovulation induction in in vitro fertilization. Gynecol. Endocrinol. 6 3 (1992) 211-224
11. Huong D.L., et al. Risks of ovulation-induction therapy in systemic lupus erythematosus. Br. J. Rheumatol. 35 11 (1996) 1184-1186
12. Speroff, L., Glass, R.H., Kase, N.G. 1989. Clinical gynecologic endocrinology and infertility. In: L. Speroff (Ed.), Induction of Ovulation. Williams and Wilkins, Baltimore, Fourth edition.
13. Guballa N., et al. Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome. Arthritis. Rheum. 43 3 (2000) 550-556
14. Khamashta M.A., and Hughes G.R. Pregnancy in systemic lupus erythematosus. Curr. Opin. Rheumatol. 8 5 (1996) 424-429
15. Geva E., et al. Undiagnosed systemic lupus erythematosus in a cohort of infertile women. Am. J. Reprod. Immunol. 51 5 (2004) 336-340
16. Nossent H.C., and Swaak T.J. Systemic lupus erythematosus. VI. Analysis of the interrelationship with pregnancy. J. Rheumatol. 17 6 (1990) 771-776
17. Kaufman R.L., and Kitridou R.C. Pregnancy in mixed connective tissue disease: comparison with systemic lupus erythematosus. J. Rheumatol. 9 4 (1982) 549-555
18. Hardy C.J., et al. Pregnancy outcome and family size in systemic lupus erythematosus: a case-control study. Rheumatology (Oxford) 38 6 (1999) 559-563
19. Park M.C., et al. Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy. Lupus 13 8 (2004) 569-574
20. Langevitz P., et al. The effect of cyclophosphamide pulses on fertility in patients with lupus nephritis. Am. J. Reprod. Immunol. 28 3-4 (1992) 157-158
21. Mok C.C., Lau C.S., and Wong R.W. Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy. Arthritis. Rheum. 41 5 (1998) 831-837
22. Boumpas D.T., et al. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann. Intern. Med. 119 5 (1993) 366-369
23. Wang C.L., Wang F., and Bosco J.J. Ovarian failure in oral cyclophosphamide treatment for systemic lupus erythematosus. Lupus 4 1 (1995) 11-14
24. Martin-Suarez I., et al. Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide. Ann. Rheum. Dis. 56 8 (1997) 481-487
25. D'Cruz D., et al. Immunosuppressive therapy in lupus nephritis. Clin. Exp. Rheumatol. 15 3 (1997) 275-282
26. Akil M., Amos R.S., and Stewart P. Infertility may sometimes be associated with NSAID consumption. Br. J. Rheumatol. 35 1 (1996) 76-78
27. Smith G., et al. Reversible ovulatory failure associated with the development of luteinized unruptured follicles in women with inflammatory arthritis taking non-steroidal anti-inflammatory drugs. Br. J. Rheumatol. 35 5 (1996) 458-462
28. Mendonca L.L., et al. Non-steroidal anti-inflammatory drugs as a possible cause for reversible infertility. Rheumatology (Oxford) 39 8 (2000) 880-882
29. Cochrane R., and Regan L. Undetected gynaecological disorders in women with renal disease. Hum. Reprod. 12 4 (1997) 667-670
30. Le Thi Huong D., Wechsler B., and Piette J.C. Ovulation induction therapy and systemic lupus erythematosus. Ann. Med. Interne. (Paris) 154 1 (2003) 45-50
31. Ben-Chetrit A., and Ben-Chetrit E. Systemic lupus erythematosus induced by ovulation induction treatment. Arthritis Rheum. 37 11 (1994) 1614-1617
32. Macut D., et al. Ovulation induction and early pregnancy loss in a woman susceptible to autoimmune diseases: a possible interrelationship. Gynecol. Endocrinol. 14 3 (2000) 153-157
33. Stratford G.A., et al. Value of thyroid function tests in routine screening of women investigated for infertility. Hum. Fertil. (Cambridge) 3 3 (2000) 203-206
34. Lincoln, S.R., Ke, R.W., Kutteh, W.H. Screening for hypothyroidism in infertile women. J. Reprod. Med. 44 (5), 455-457.
35. Joshi J.V., et al. Menstrual irregularities and lactation failure may precede thyroid dysfunction or goiter. J. Postgrad. Med. 39 3 (1993) 137-141
36. Strickland D.M., Whitted W.A., and Wians Jr. F.H. Screening infertile women for subclinical hypothyroidism. Am. J. Obstet. Gynecol. 163 1.1 (1990) 262-263
37. Brenner P.F. Differential diagnosis of abnormal uterine bleeding. Am. J. Obstet. Gynecol. 175 3.2 (1996) 766-769
38. Louvet J.P., et al. Hypothyroidism and anovulation. Lancet 1 8124 (1979) 1032
39. Goldsmith R.E., et al. The menstrual pattern in thyroid disease. J. Clin. Endocrinol. Metab. 12 7 (1952) 846-855
40. Thomas R., and Reid R.L. Thyroid disease and reproductive dysfunction: a review. Obstet. Gynecol. 70 5 (1987) 789-798
41. Wing D.A., et al. A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am. J. Obstet. Gynecol. 170 1.1 (1994) 90-95
42. Geva E., et al. Autoimmunity and reproduction. Fertil. Steril. 67 4 (1997) 599-611
43. Matalon S.T., et al. The association between anti-thyroid antibodies and pregnancy loss. Am. J. Reprod. Immunol. 45 2 (2001) 72-77
44. Roussev R.G., et al. Laboratory evaluation of women experiencing reproductive failure. Am. J. Reprod. Immunol. 35 4 (1996) 415-420
45. Kutteh W.H., et al. Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction. Fertil. Steril. 71 5 (1999) 843-848
46. Rushworth F.H., et al. Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies. Hum. Reprod. 15 7 (2000) 1637-1639
47. Bussen S., Steck T., and Dietl J. Increased prevalence of thyroid antibodies in euthyroid women with a history of recurrent in-vitro fertilization failure. Hum. Reprod. 15 3 (2000) 545-548
48. Kutteh W.H., Schoolcraft W.B., and Scott Jr. R.T. Antithyroid antibodies do not affect pregnancy outcome in women undergoing assisted reproduction. Hum. Reprod. 14 11 (1999) 2886-2890
49. Muller A.F., et al. Thyroid autoimmunity and abortion: a prospective study in women undergoing in vitro fertilization. Fertil. Steril. 71 1 (1999) 30-34
50. Magaro M., et al. The association of silent thyroiditis with active systemic lupus erythematosus. Clin. Exp. Rheumatol. 10 1 (1992) 67-70
51. Kjaer K., et al. Epidemiology of menarche and menstrual disturbances in an unselected group of women with insulin-dependent diabetes mellitus compared to controls. J. Clin. Endocrinol. Metab. 75 2 (1992) 524-529
52. Yeshaya A., et al. Menstrual characteristics of women suffering from insulin-dependent diabetes mellitus. Int. J. Fertil. Menopausal. Stud. 40 5 (1995) 269-273
53. Griffin M.L., et al. Insulin-dependent diabetes mellitus and menstrual dysfunction. Ann. Med. 26 5 (1994) 331-340
54. Lord, J.M., Flight, I.H., Norman, R.J. 2003. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. Cochrane Database Syst. Rev. (3), CD003053.
55. Kjaer K., et al. Infertility and pregnancy outcome in an unselected group of women with insulin-dependent diabetes mellitus. Am. J. Obstet. Gynecol. 166 5 (1992) 1412-1418
56. Kalter H. Diabetes and spontaneous abortion: a historical review. Am. J. Obstet. Gynecol. 156 5 (1987) 1243-1253
57. Miodovnik M., et al. Spontaneous abortion among insulin-dependent diabetic women. Am. J. Obstet. Gynecol. 150 4 (1984) 372-376
58. Miodovnik M., et al. Elevated maternal glycohemoglobin in early pregnancy and spontaneous abortion among insulin-dependent diabetic women. Am. J. Obstet. Gynecol. 153 4 (1985) 439-442
59. Dicker D., et al. Spontaneous abortion in patients with insulin-dependent diabetes mellitus: the effect of preconceptional diabetic control. Am. J. Obstet. Gynecol. 158 5 (1988) 1161-1164
60. Nelson J.L., et al. Fecundity before disease onset in women with rheumatoid arthritis. Arthritis Rheum. 36 1 (1993) 7-14
61. Del Junco, D.J., et al. 1989. The relationship between rheumatoid arthritis and reproductive function. Br. J. Rheumatol. 28 (Suppl. 1) 33; discussion 42-45.
62. Kaplan D. Fetal wastage in patients with rheumatoid arthritis. J. Rheumatol. 13 5 (1986) 875-877
63. Brennan P., et al. Oral contraceptives and rheumatoid arthritis: results from a primary care-based incident case-control study. Semin. Arthritis Rheum. 26 6 (1997) 817-823
64. Steen V.D., and Medsger Jr. T.A. Fertility and pregnancy outcome in women with systemic sclerosis. Arthritis Rheum. 42 4 (1999) 763-768
65. Launay D., et al. Systemic sclerosis and pregnancy. Rev. Med. Interne. 23 7 (2002) 607-621
66. Rabhi M., et al. Scleroderma and pregnancy. Ann. Med. Interne. (Paris) 153 3 (2002) 193-200
67. Silman A.J., and Black C. Increased incidence of spontaneous abortion and infertility in women with scleroderma before disease onset: a controlled study. Ann. Rheum. Dis. 47 6 (1988) 441-444
68. Lambe M., et al. Childbearing and the risk of scleroderma: a population-based study in Sweden. Am. J. Epidemiol. 159 2 (2004) 162-166
69. D'Angelo S., et al. Low-dose intravenous cyclophosphamide in systemic sclerosis: a preliminary safety study. Clin. Rheumatol. 22 6 (2003) 393-396
70. Betterle C., and Volpato M. Adrenal and ovarian autoimmunity. Eur. J. Endocrinol. 138 1 (1998) 16-25
71. Lovas K., and Husebye E.S. High prevalence and increasing incidence of Addison's disease in western Norway. Clin. Endocrinol. (Oxford) 56 6 (2002) 787-791
72. Anasti J.N. Premature ovarian failure: an update. Fertil. Steril. 70 1 (1998) 1-15
73. Betterle C., et al. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr. Rev. 23 3 (2002) 327-364
74. Chen S., et al. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure. J. Clin. Endocrinol. Metab. 81 5 (1996) 1871-1876
75. Betterle C., et al. Premature ovarian failure: autoimmunity and natural history. Clin. Endocrinol. (Oxford) 39 1 (1993) 35-43
76. Coulam C.B., Adamson S.C., and Annegers J.F. Incidence of premature ovarian failure. Obstet. Gynecol. 67 4 (1986) 604-606
77. LaBarbera A.R., et al. Autoimmune etiology in premature ovarian failure. Am. J. Reprod. Immunol. Microbiol. 16 3 (1988) 115-122
78. Kalantaridou, S.N., Nelson, L.M. Premature ovarian failure is not premature menopause. Ann. N. Y. Acad. Sci. 900, 393-402.
79. Kim T.J., et al. Routine endocrine screening for patients with karyotypically normal spontaneous premature ovarian failure. Obstet. Gynecol. 89 5.1 (1997) 777-779
80. Irvine W.J., et al. Immunological aspects of premature ovarian failure associated with idiopathic Addison's disease. Lancet 2 7574 (1968) 883-887
81. Alper M.M., Jolly M.M., and Garner P.R. Pregnancies after premature ovarian failure. Obstet. Gynecol. 67 Suppl. 3 (1986) 59S-62S
82. Kreiner D., et al. Spontaneous and pharmacologically induced remissions in patients with premature ovarian failure. Obstet. Gynecol. 72 6 (1988) 926-928
83. Nelson L.M., et al. Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J. Clin. Endocrinol. Metab. 79 5 (1994) 1470-1475
84. Kalantaridou S.N., Davis S.R., and Nelson L.M. Premature ovarian failure. Endocrinol. Metab. Clin. N. Am. 27 4 (1998) 989-1006
85. Morris R.S., and Sauer M.V. New advances in the treatment of infertility in women with ovarian failure. Curr. Opin. Obstet. Gynecol. 5 3 (1993) 368-377
86. Corenblum B., Rowe T., and Taylor P.J. High-dose, short-term glucocorticoids for the treatment of infertility resulting from premature ovarian failure. Fertil. Steril. 59 5 (1993) 988-991
87. Kalantaridou S.N., et al. Treatment of autoimmune premature ovarian failure. Hum. Reprod. 14 7 (1999) 1777-1782
88. van Kasteren Y.M., et al. Corticosteroids do not influence ovarian responsiveness to gonadotropins in patients with premature ovarian failure: a randomized, placebo-controlled trial. Fertil. Steril. 71 1 (1999) 90-95
89. Kauffman R.P., and Castracane V.D. Premature ovarian failure associated with autoimmune polyglandular syndrome: pathophysiological mechanisms and future fertility. J. Womens Health (Larchmt) 12 5 (2003) 513-520
90. Sauer M.V., et al. Three hundred cycles of oocyte donation at the University of Southern California: assessing the effect of age and infertility diagnosis on pregnancy and implantation rates. J. Assist. Reprod. Genet. 11 2 (1994) 92-96
91. Lydic M.L., et al. Success of donor oocyte in in vitro fertilization-embryo transfer in recipients with and without premature ovarian failure. Fertil. Steril. 65 1 (1996) 98-102
92. Kutteh W.H., Rote N.S., and Silver R. Antiphospholipid antibodies and reproduction: the antiphospholipid antibody syndrome. Am. J. Reprod. Immunol. 41 2 (1999) 133-152
93. Gleicher N., Vidali A., and Karande V. The immunological Wars of the Roses: disagreements amongst reproductive immunologists. Hum. Reprod. 17 3 (2002) 539-542
94. Balasch J., et al. Antiphospholipid antibodies and human reproductive failure. Hum. Reprod. 11 10 (1996) 2310-2315
95. Radojcic L., et al. Anticardiolipin antibodies in women with unexplained infertility. Physiol. Res. 53 1 (2004) 91-96
96. Lockshin M.D. Autoimmunity, infertility and assisted reproductive technologies. Lupus 13 9 (2004) 669-672
97. Hornstein M.D., et al. Antiphospholipid antibodies and in vitro fertilization success: a meta-analysis. Fertil. Steril. 73 2 (2000) 330-333
98. Kutteh W.H. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am. J. Obstet. Gynecol. 174 5 (1996) 1584-1589
99. Sher, G., et al., High fecundity rates following in-vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin. Hum. Reprod. 9 (12), 2278-2283.
100. Coulam C.B., Krysa L.W., and Bustillo M. Intravenous immunoglobulin for in-vitro fertilization failure. Hum. Reprod. 9 12 (1994) 2265-2269
101. Stern C., et al. A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies. Fertil. Steril. 80 2 (2003) 376-383
102. Pregnancy-related death associated with heparin and aspirin treatment for infertility, 1996 MMWR. Morb. Mortal. Wkly. Rep. 1998. 47 (18) 368-371.
103. Janssen N.M., and Genta M.S. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch. Intern. Med. 160 5 (2000) 610-619
104. Sills E.S., et al. Successful ovulation induction, conception, and normal delivery after chronic therapy with etanercept: a recombinant fusion anti-cytokine treatment for rheumatoid arthritis. Am. J. Reprod. Immunol. 46 5 (2001) 366-368
105. Blumenfeld Z., et al. Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy. Lupus 9 6 (2000) 401-405
106. Hatasaka H. Immunologic factors in infertility. Clin. Obstet. Gynecol. 43 4 (2000) 830-843
107. Birkenfeld A., et al. Incidence of autoimmune antibodies in failed embryo transfer cycles. Am. J. Reprod. Immunol. 31 2-3 (1994) 65-68
108. Schenk, L.M., Butler, L., Monis, J.P., Cox, B., Leete, J., Abuhamed, A., Oehninger, S., Muasher, S. 1996. Heparin and aspirin treatment yields higher implantation rates in IVF patients with antiphospholipid antibody seropositivity compared to untreated seronegative patients. In: 52nd Annual Meeting of the American Society for Reproductive Medicine [Abstract O-076] (data updated from presentation). November 2-6, Boston.
109. Kutteh W.H., et al. Effect of antiphospholipid antibodies in women undergoing in-vitro fertilization: role of heparin and aspirin. Hum. Reprod. 12 6 (1997) 1171-1175
110. Sher G., et al. The selective use of heparin/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization. Am. J. Reprod. Immunol. 40 2 (1998) 74-82
111. Geva E., et al. Prednisone and aspirin improve pregnancy rate in patients with reproductive failure and autoimmune antibodies: a prospective study. Am. J. Reprod. Immunol. 43 1 (2000) 36-40